Sequence-based prediction of SARS-CoV-2 vaccine targets using a mass spectrometry-based bioinformatics predictor identifies immunogenic T cell epitopes
Asaf Poran(BioNTech (United States)), Richard B. Gaynor(BioNTech (United States)), Marit M. van Buuren(The Netherlands Cancer Institute), Daniel Rothenberg(Brighton Hospital), Divya Lenkala(BioNTech (United States)), Terri A. Addona(BioNTech (United States)), Dewi Harjanto(BioNTech (United States)), Christina M. Arieta(BioNTech (United States)), Michael S. Rooney(BioNTech (United States)), Matthew Malloy(BioNTech (United States)), Lakshmi Srinivasan(Royal Stoke University Hospital)
Cited by 101
Related Papers
Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer
|Journal of Clinical Investigation|2001|1.6k
Resistance to checkpoint blockade therapy through inactivation of antigen presentation
|Nature Communications|2017|999
Tumor Exome Analysis Reveals Neoantigen-Specific T-Cell Reactivity in an Ipilimumab-Responsive Melanoma
|Journal of Clinical Oncology|2013|799
High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma
|Nature Medicine|2014|692
PI3 Kinase Signals BCR-Dependent Mature B Cell Survival
|Cell|2009|651